A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies

被引：10

作者：

Conte, Benedetta ^{[1
,2
]}

Braso-Maristany, Fara ^{[1
,2
,3
]}

Hernandez, Adela Rodriguez ^{[1
,2
]}

Pascual, Tomas ^{[1
,2
,4
]}

Villacampa, Guillermo ^{[3
,4
,5
]}

Schettini, Francesco ^{[1
,2
,6
]}

Losada, Maria J. Vidal ^{[1
,2
,4
,6
,7
]}

Segui, Elia ^{[1
,2
,4
]}

Angelats, Laura ^{[1
,2
]}

Garcia-Fructuoso, Isabel ^{[1
,2
]}

Gomez-Bravo, Raquel ^{[1
,2
]}

Lorman-Carbo, Natalia ^{[1
]}

Pare, Laia ^{[3
]}

Marin-Aguilera, Mercedes ^{[3
]}

Martinez-Saez, Olga ^{[1
,2
]}

Adamo, Barbara ^{[1
,2
]}

Sanfeliu, Esther ^{[1
,8
]}

Fratini, Beatrice ^{[1
]}

Falato, Claudette ^{[1
,4
]}

Chic, Nuria ^{[1
,2
]}

Vivancos, Ana ^{[3
,9
]}

Villagrasa, Patricia ^{[3
]}

Staaf, Johan ^{[10
]}

Parker, Joel S. ^{[11
]}

Perou, Charles M. ^{[11
,12
]}

Prat, Aleix ^{[1
,2
,3
,6
,7
]}

机构：

[1] August Pi i Sunyer Biomed Res Inst IDIBAPS, Translat Genom & Targeted Therapies Solid Tumors G, Barcelona, Spain

[2] Hosp Clin Barcelona, Canc Inst & Blood Dis, Barcelona, Spain

[3] Reveal Genom, Barcelona, Spain

[4] SOLTI Cooperat Grp, Barcelona, Spain

[5] Vall dHebron Inst Oncol, Oncol Data Sci, Barcelona, Spain

[6] Univ Barcelona, Dept Med, Barcelona, Spain

[7] Hosp QuironSalud, Inst Oncol IOB, Barcelona, Spain

[8] Hosp Clin Barcelona, Pathol Dept, Barcelona, Spain

[9] Vall dHebron Inst Oncol VHIO, Canc Genom Grp, Barcelona, Spain

[10] Lund Univ, Dept Lab Med, Div Translat Canc Res, Lund, Sweden

[11] Univ N Carolina, Dept Genet, Chapel Hill, NC USA

[12] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA

来源：

EBIOMEDICINE | 2024年 / 102卷

关键词：

Triple-negative breast cancer (TNBC); Pathological complete response (pCR); Event-free survival (EFS); Overall survival (OS); B-cell/immunoglobulin signature (IGG); Prognostic biomarkers; Predictive biomarkers; Gene expression; TUMOR-INFILTRATING LYMPHOCYTES; STANDARD NEOADJUVANT CHEMOTHERAPY; PATHOLOGICAL COMPLETE RESPONSE; RANDOMIZED PHASE-II; PROGNOSTIC VALUE; PREDICTIVE-VALUE; CARBOPLATIN; PACLITAXEL; RISK; DOXORUBICIN;

D O I：

10.1016/j.ebiom.2024.105043

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background Early -stage triple -negative breast cancer (TNBC) displays clinical and biological diversity. From a biological standpoint, immune infiltration plays a crucial role in TNBC prognosis. Currently, there is a lack of genomic tools aiding in treatment decisions for TNBC. This study aims to assess the effectiveness of a B -cell/ immunoglobulin signature (IGG) alone, or in combination with tumor burden, in predicting prognosis and treatment response in patients with TNBC. Methods Genomic and clinical data were retrieved from 7 cohorts: SCAN -B (N = 874), BrighTNess (n = 482), CALGB40603 (n = 389), METABRIC (n = 267), TCGA (n = 118), GSE58812 (n = 107), GSE21653 (n = 67). IGG and a risk score integrating IGG with tumor/nodal staging (IGG-Clin) were assessed for event -free survival (EFS) and overall survival (OS) in each cohort. Random effects model was used to derive pooled effect sizes. Association of IGG with pathological complete response (pCR) was assessed in CALGB-40603 and BrighTNess. Immune significance of IGG was estimated through CIBERSORTx and EcoTyper. Findings IGG was associated with improved EFS (pooled HR = 0.77, [95% CI = 0.70-0.85], I2 = 18%) and OS (pooled HR = 0.79, [0.73-0.85], I2 = 0%) across cohorts, and was predictive of pCR in CALGB-40603 (OR 1.25, [1.10-1.50]) and BrighTNess (OR 1.57 [1.25-1.98]). IGG-Clin was predictive of recurrence (pooled HR = 2.11, [1.75-2.55], I2 = 0%) and death (pooled HR = 1.99, 95% [0.84-4.73], I2 = 79%) across cohorts. IGG was associated with adaptive immune response at CIBERSORTx and EcoTyper analysis. Interpretation IGG is linked to improved prognosis and pCR in early -stage TNBC. The integration of IGG alongside tumor and nodal staging holds promise as an approach to identify patients benefitting from intensified or deintensified treatments. Agencia de Gesto d'Ajuts Universitaris i de Recerca, Instituto de Salud Carlos III, Fundacion Contigo, Asociacion Cancer de Mama Metastasico IV, Breast Cancer Research Foundation, RESCUER, Fundacion cientifica AECC and FSEOM. Copyright (c) 2024 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

引用

页数：15

共 70 条

[1] Subtyping of Triple-Negative Breast Cancer: Implications for Therapy [J].

Abramson, Vandana G. ;

Lehmann, Brian D. ;

Ballinger, Tarah J. ;

Pietenpol, Jennifer A. .

CANCER, 2015, 121 (01) :8-16

[2] Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199 [J].

Adams, Sylvia ;

Gray, Robert J. ;

Demaria, Sandra ;

Goldstein, Lori ;

Perez, Edith A. ;

Shulman, Lawrence N. ;

Martino, Silvana ;

Wang, Molin ;

Jones, Vicky E. ;

Saphner, Thomas J. ;

Wolff, Antonio C. ;

Wood, William C. ;

Davidson, Nancy E. ;

Sledge, George W. ;

Sparano, Joseph A. ;

Badve, Sunil S. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :2959-+

[3] Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression [J].

Ando, Masashi ;

Yamauchi, Hideko ;

Aogi, Kenjiro ;

Shimizu, Satoru ;

Iwata, Hiroji ;

Masuda, Norikazu ;

Yamamoto, Naohito ;

Inoue, Kenichi ;

Ohono, Shinji ;

Kuroi, Katsumasa ;

Hamano, Tetsutaro ;

Sukigara, Tamie ;

Fujiwara, Yasuhiro .

BREAST CANCER RESEARCH AND TREATMENT, 2014, 145 (02) :401-409

[4] Clinical Value of RNA Sequencing-Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network-Breast Initiative [J].

Brueffer, Christian ;

Vallon-Christersson, Johan ;

Grabau, Dorthe ;

Ehinger, Anna ;

Hakkinen, Jari ;

Hegardt, Cecilia ;

Malina, Janne ;

Chen, Yilun ;

Bendahl, Par-Ola ;

Manjer, Jonas ;

Malmberg, Martin ;

Larsson, Christer ;

Loman, Niklas ;

Ryden, Lisa ;

Borg, Ake ;

Saal, Lao H. .

JCO PRECISION ONCOLOGY, 2018, 2 :1-18

[5] Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab [J].

Bueno-Muino, Coralia ;

Echavarria, Isabel ;

Lopez-Tarruella, Sara ;

Roche-Molina, Marta ;

del Monte-Millan, Maria ;

Massarrah, Tatiana ;

Jerez, Yolanda ;

de la Pena, Francisco Ayala ;

Garcia-Saenz, Jose angel ;

Moreno, Fernando ;

Rodriguez-Lescure, Alvaro ;

Malon-Gimenez, Diego ;

Garcia, Ana Isabel Ballesteros ;

Marin-Aguilera, Mercedes ;

Galvan, Patricia ;

Braso-Maristany, Fara ;

Waks, Adrienne G. G. ;

Tolaney, Sara M. M. ;

Mittendorf, Elizabeth A. A. ;

Vivancos, Ana ;

Villagrasa, Patricia ;

Parker, Joel. S. ;

Perou, Charles M. M. ;

Pare, Laia ;

Villacampa, Guillermo ;

Prat, Aleix ;

Martin, Miguel .

JAMA ONCOLOGY, 2023, 9 (06) :841-846

[6] Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis [J].

Cortazar, Patricia ;

Zhang, Lijun ;

Untch, Michael ;

Mehta, Keyur ;

Costantino, Joseph P. ;

Wolmark, Norman ;

Bonnefoi, Herve ;

Cameron, David ;

Gianni, Luca ;

Valagussa, Pinuccia ;

Swain, Sandra M. ;

Prowell, Tatiana ;

Loibl, Sibylle ;

Wickerham, D. Lawrence ;

Bogaerts, Jan ;

Baselga, Jose ;

Perou, Charles ;

Blumenthal, Gideon ;

Blohmer, Jens ;

Mamounas, Eleftherios P. ;

Bergh, Jonas ;

Semiglazov, Vladimir ;

Justice, Robert ;

Eidtmann, Holger ;

Paik, Soonmyung ;

Piccart, Martine ;

Sridhara, Rajeshwari ;

Fasching, Peter A. ;

Slaets, Leen ;

Tang, Shenghui ;

Gerber, Bernd ;

Geyer, Charles E., Jr. ;

Pazdur, Richard ;

Ditsch, Nina ;

Rastogi, Priya ;

Eiermann, Wolfgang ;

von Minckwitz, Gunter .

LANCET, 2014, 384 (9938) :164-172

[7] Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy [J].

de Jong, Vincent M. T. ;

Wang, Yuwei ;

ter Hoeve, Natalie D. ;

Opdam, Mark ;

Stathonikos, Nikolas ;

Jozwiak, Katarzyna ;

Hauptmann, Michael ;

Cornelissen, Sten ;

Vreuls, Willem ;

Rosenberg, Efraim H. ;

Koop, Esther A. ;

Varga, Zsuzsanna ;

van Deurzen, Carolien H. M. ;

Mooyaart, Antien L. ;

Cordoba, Alicia ;

Groen, Emma J. ;

Bart, Joost ;

Willems, Stefan M. ;

Zolota, Vasiliki ;

Wesseling, Jelle ;

Sapino, Anna ;

Chmielik, Ewa ;

Ryska, Ales ;

Broeks, Annegien ;

Voogd, Adri C. ;

Loi, Sherene ;

Michiels, Stefan ;

Sonke, Gabe S. ;

van der Wall, Elsken ;

Siesling, Sabine ;

van Diest, Paul J. ;

Schmidt, Marjanka K. ;

Kok, Marleen ;

Dackus, Gwen M. H. E. ;

Salgado, Roberto ;

Linn, Sabine C. .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (21) :2361-+

[8] Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy [J].

Denkert, Carsten ;

von Minckwitz, Gunter ;

Darb-Esfahani, Silvia ;

Lederer, Bianca ;

Heppner, Barbara I. ;

Weber, Karsten E. ;

Budczies, Jan ;

Huober, Jens ;

Klauschen, Frederick ;

Furlanetto, Jenny ;

Schmitt, Wolfgang D. ;

Blohmer, Jens-Uwe ;

Karn, Thomas ;

Pfitzner, Berit M. ;

Kuemmel, Sherko ;

Engels, Knut ;

Schneeweiss, Andreas ;

Hartmann, Arndt ;

Noske, Aurelia ;

Fasching, Peter A. ;

Jackisch, Christian ;

van Mackelenbergh, Marion ;

Sinn, Peter ;

Schem, Christian ;

Hanusch, Claus ;

Untch, Michael ;

Loibl, Sibylle .

LANCET ONCOLOGY, 2018, 19 (01) :40-50

[9] Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive and Triple-Negative Primary Breast Cancers [J].

Denkert, Carsten ;

von Minckwitz, Gunter ;

Brase, Jan C. ;

Sinn, Bruno V. ;

Gade, Stephan ;

Kronenwett, Ralf ;

Pfitzner, Berit M. ;

Salat, Christoph ;

Loi, Sherene ;

Schmitt, Wolfgang D. ;

Schem, Christian ;

Fisch, Karin ;

Darb-Esfahani, Silvia ;

Mehta, Keyur ;

Sotiriou, Christos ;

Wienert, Stephan ;

Klare, Peter ;

Andre, Fabrice ;

Klauschen, Frederick ;

Blohmer, Jens-Uwe ;

Krappmann, Kristin ;

Schmidt, Marcus ;

Tesch, Hans ;

Kuemmel, Sherko ;

Sinn, Peter ;

Jackisch, Christian ;

Dietel, Manfred ;

Reimer, Toralf ;

Untch, Michael ;

Loibl, Sibylle .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (09) :983-991

[10] Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer [J].

Denkert, Carsten ;

Loibl, Sibylle ;

Noske, Aurelia ;

Roller, Marc ;

Mueller, Berit Maria ;

Komor, Martina ;

Budczies, Jan ;

Darb-Esfahani, Silvia ;

Kronenwett, Ralf ;

Hanusch, Claus ;

von Toerne, Christian ;

Weichert, Wilko ;

Engels, Knut ;

Solbach, Christine ;

Schrader, Iris ;

Dietel, Manfred ;

von Minckwitz, Gunter .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :105-113

← 1 2 3 4 5 6 7 →